Combined surgical and antifungal treatment of subcutaneous infection due to Paecilomyces lilacinus

Medical Mycology

Volumn 41, Issue 3, 2003, Pages 253-258

  Kurzai, Oliver ^a   Vaeth, T ^a   Hamelmann, W ^a   Muller F M C ^a   Klinker, H ^a   Langmann, P ^a   Frosch, M ^a   Muhlschlegel F ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Antifungal therapy; Liver cirrhosis; Paecilomyces lilacinus; Subcutaneous infection

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CASPOFUNGIN; CEFOTAXIME; CREATININE; FLUCONAZOLE; FUROSEMIDE; GRISEOFULVIN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; LACTULOSE; METRONIDAZOLE; MICAFUNGIN; MICONAZOLE; OMEPRAZOLE; POSACONAZOLE; PROPRANOLOL; RAVUCONAZOLE; SPIRONOLACTONE; TERBINAFINE; TOBRAMYCIN; VORICONAZOLE;

ABSCESS; ADULT; AFRICA; ARTICLE; CASE REPORT; DIET RESTRICTION; DILUTION; DRUG EFFECT; DRUG SCREENING; ESOPHAGUS VARICES; FUNGUS ISOLATION; GASTROINTESTINAL HEMORRHAGE; HEPATITIS B VIRUS; HUMAN; HYPERSPLENISM; IN VITRO STUDY; KIDNEY FAILURE; LEUKOPENIA; LIVER CIRRHOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT DEPARTMENT; PAECILOMYCES LILACINUS; RETROSPECTIVE STUDY; SKIN EDEMA; SKIN INFECTION; SYSTEMIC THERAPY; THROMBOCYTOPENIA;

ABSCESS; ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; COMBINED MODALITY THERAPY; DERMATOMYCOSES; GERMANY; HUMANS; LIVER CIRRHOSIS; MALE; MICROBIAL SENSITIVITY TESTS; PAECILOMYCES;

FUNGI; HEPATITIS B VIRUS; PAECILOMYCES; PAECILOMYCES LILACINUS;

EID: 0042324790     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/1369378031000147467     Document Type: Article

References (28)

1. De Hoog GAS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi, 2nd edn. Utrecht, The Netherlands: Centraalbureau voor Schimmelcultures, 2001.
2. Castro LGM, Salebian A, Sotto MN. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J Med Vet Mycol 1990; 28: 15-26.
3. Orth B, Frei R, Itin PH, et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 1996; 125: 799-806.
4. Itin PH, Frei R, Lautenschlager S, et al. Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. J Am Acad Dermatol 1998; 39: 401-409.
5. Hecker MS, Weinberg JM, Bagheri B, et al. Cutaneous Paecilomyces lilacinus infection: Report of two novel cases. J Am Acad Dermatol 1997; 37: 270-271.
6. Catro LG. Cutaneous Paecilomyces lilacinus infection. J Am Acad Dermatol 1998; 39: 516-517.
7. Fletcher CL, Hay RJ, Midgley G, Moore M. Onychomycosis caused by infection with Paecilomyces lilacinus. Br J Dermatol 1998; 139: 1133-1135.
8. Clark NM. Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinafine. Clin Infect Dis 1999; 28: 1169-1170.
9. Gutierrez-Rodero F, Morganon M, Ortiz De La Tabla V, Mayoll MJ, Martin C. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: Case report and review. Eur J Clin Microbiol Infect Dis 1999; 18: 814-818.
10. Hilmarsdottir H, Thorsteinsson SB, Asmundsson P, Bodvarsson M, Arnadottir M. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: Treatment with voriconazole. Scand J Infect Dis 2000; 32: 331-332.
11. Blackwell V, Ahmed K, Docherty CO, Hay RJ. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in a renal transplant patient. Br J Dermatol 2000; 143: 873-875.
12. Gottllieb T, Atkins BL. Case report. Successful treatment of cutaneous Paecilomyces lilacinus infection with oral itraconazole in an immune competent host. Mycoses 2001; 44: 513-515.
13. Safdar A. Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: Rapid response to treatment with caspofungin and itraconazole. Clin Infect Dis 2002; 34: 1415-1417.
14. Gucalp R, Carlisle P, Gialanella P, Mitsudo S, McKitrick J, Dutcher J. Paecilomyces sinusitis in an immunocompromised adult patient: Case report and review. Clin Infect Dis 1996; 23: 391-393.
15. Saberhagen C, Klotz SA, Bartholomew W, Drews D, Dixon A. Infection due to Paecilomyces lilacinus: A challenging clinical identification. Clin Infect Dis 1997; 25: 1411-1413.
16. Chan-Tack KM, Thio CL, Miller NS, Karp CL, Ho C, Merz WG. Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. Med Mycol 1999; 37: 57-60.
17. Scott IU, Flynn Jr. HW, Miller D, Speights JW, Snip RC, Brod RD. Exogenous endophthalmitis caused by amphotericin B-resistant Paecilomyces lilacinus: Treatment options and visual outcomes. Arch Ophthalmol 2001; 119: 916-919.
18. Tan TQ, Ogden AK, Tillman J, Demmler GJ, Rinaldi MG. Paecilomyces lilacinus catheder-related fungemia in an immuno-compromised pediatric patient. J Clin Microbiol 1992; 30: 2479-2483.
19. Westenfeld F, Alston WK, Winn WC. Complicated soft tissue infection with prepatellar bursitis caused by Paecilomyces lilacinus in an immunocompetent host: Case report and review. J Clin Microbiol 1996; 34: 1559-1562.
20. Espinel-Ingroff A. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic fungi. J Clin Microbiol 2001; 39: 1360-1367.
21. Szekely A, Johnson EM, Warnock DW. Comparison of E-tests and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol 1999; 37: 1480-1483.
22. Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces and Acremonium species by histopathology. Am J Clin Pathol 1998; 109: 45-54.
23. Kac G, Piriou P, Gúeho E, Roux P, Trémoulet J, Denis M, Judet T. Osteoarthritis caused by Neocosmospora vasinfecta. Med Mycol 1999; 37: 213-217.
24. Kurzai O, El Barkani A, Mühlschlegel FA. Adaptation of fungi to alterations of the environmental ph. In: Calderone R, Cihlar R (eds). Fungal Pathogenesis - Principles and Clinical Applications. New York: Marcel Dekker, 2001; 139-160.
25. Kurzai O, Heinz WJ, Mühlschlegel FA. ASM Conference: Candida and Candidiasis. Mycoses 1999; 42: 427-430.
26. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39: 954-958.
27. Garbino J, Ondrusova A, Baligvo E, Lew D, Bouchuiguir-Wafa K, Rohner P. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 2002; 34: 701-703.
28. Martin CA, Roberts S, Greenberg RN. Voriconazole treatment of disseminated Paecilomyces lilacinus infection in a patient with Acquired Immunodeficiency Syndrome. Clin Inf Dis 2002; 35: 78-81.